OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Harnessing natural killer cell effector function against cancer
Matthew D. Blunt, Salim I. Khakoo
Immunotherapy Advances (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 9
Matthew D. Blunt, Salim I. Khakoo
Immunotherapy Advances (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 9
Showing 9 citing articles:
Research Developments in Cancer Hallmarks and Immune Checkpoints Based on Mechanisms of Tumour Microenvironment
Chao Jin
Theoretical and Natural Science (2025) Vol. 90, Iss. 1, pp. 38-47
Closed Access
Chao Jin
Theoretical and Natural Science (2025) Vol. 90, Iss. 1, pp. 38-47
Closed Access
MICB Genetic Variants and Its Protein Soluble Level Are Associated with the Risk of Chronic GvHD and CMV Infection after Allogeneic HSCT
Jagoda Siemaszko, Marta Dratwa, Agnieszka Szeremet, et al.
Archivum Immunologiae et Therapiae Experimentalis (2024) Vol. 72, Iss. 1
Closed Access | Times Cited: 2
Jagoda Siemaszko, Marta Dratwa, Agnieszka Szeremet, et al.
Archivum Immunologiae et Therapiae Experimentalis (2024) Vol. 72, Iss. 1
Closed Access | Times Cited: 2
NKG2A genetic deletion promotes human primary NK cell anti-tumor responses better than an anti-NKG2A monoclonal antibody
Ying Gong, Wilfred T.V. Germeraad, Xu‐Lin Zhang, et al.
Molecular Therapy (2024) Vol. 32, Iss. 8, pp. 2711-2727
Open Access | Times Cited: 2
Ying Gong, Wilfred T.V. Germeraad, Xu‐Lin Zhang, et al.
Molecular Therapy (2024) Vol. 32, Iss. 8, pp. 2711-2727
Open Access | Times Cited: 2
B‐cell performance in chemotherapy: Unravelling the mystery of B‐cell therapeutic potential
Zizhuo Li, Anqi Lin, Zhifei Gao, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 7
Open Access | Times Cited: 1
Zizhuo Li, Anqi Lin, Zhifei Gao, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 7
Open Access | Times Cited: 1
NK Cells in the Lymph Nodes and Their Role in Anti-Tumour Immunity
Lara V. Graham, Salim I. Khakoo, Matthew D. Blunt
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1667-1667
Open Access | Times Cited: 1
Lara V. Graham, Salim I. Khakoo, Matthew D. Blunt
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1667-1667
Open Access | Times Cited: 1
Cellular and transcriptional profiles of peripheral blood mononuclear cells pre-vaccination predict immune response to preventative MUC1 vaccine
Daniel Y. Yuan, Michelle L. McKeague, Vineet K. Raghu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Daniel Y. Yuan, Michelle L. McKeague, Vineet K. Raghu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
KIR2DS2+ NK cells in cancer patients demonstrate high activation in response to tumour-targeting antibodies
Lara V. Graham, Jack G. Fisher, Amber D. P. Doyle, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Lara V. Graham, Jack G. Fisher, Amber D. P. Doyle, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Natural Killer Cells in Anti-Tumour Immunity
Lara V. Graham, Matthew D. Blunt
Elsevier eBooks (2024)
Closed Access
Lara V. Graham, Matthew D. Blunt
Elsevier eBooks (2024)
Closed Access
Advances in CAR NK Cell Therapy for Targeting and Eradicating Circulating Tumor Cells: Challenges and Solutions for Aging Patients Mini Review
Dmitri Toren, Eugen Ursu, Bogdan Ghilic-Micu, et al.
Ageing & Longevity (2024), Iss. 4 2024, pp. 157-173
Open Access
Dmitri Toren, Eugen Ursu, Bogdan Ghilic-Micu, et al.
Ageing & Longevity (2024), Iss. 4 2024, pp. 157-173
Open Access
